Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Autoantibody and Immunologic Cell Marker Study

NCT02422875 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT02422875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02422875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Autoantibody and Immunologic Cell Marker Study
Lead sponsor
Emory University
Phase
Observational
Overall status
Enrolling by invitation
Start date
August 31, 2012
Completion date
May 31, 2028
Enrollment
2,500 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, communicable diseases, lupus erythematosus, systemic